Role of nitric oxide in the circulatory failure and organ injury in a rodent model of Gram-positive shock

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1411-1421

  Kengatharan, Ken M ^a   De Kimpe, Sjef J ^a   Thiemermann, Christoph ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Circulatory failure; Lipoteichoic acid; Multiple organ injury; Nitric oxide synthase; Peptidoglycan; Septic shock

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOGUANIDINE; CREATININE; DEXAMETHASONE; LIPOTEICHOIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PEPTIDOGLYCAN; TUMOR NECROSIS FACTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTERIAL OXYGEN TENSION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME INDUCTION; GRAM POSITIVE BACTERIUM; HEMODYNAMICS; HYPOTENSION; KIDNEY; KIDNEY DISEASE; LIVER; LIVER CELL DAMAGE; LUNG; MALE; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY FAILURE; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; TACHYCARDIA; UREA BLOOD LEVEL;

EID: 0029803759     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16053.x     Document Type: Article

References (56)

1. ABATE, A., KENGATHARAN, M., RUETTEN, H., HIRSCHELMANN, R., THIEMERMANN, C. & VANE, J.R. (1996). Induction of cyclooxygenase-2 by lipoteichioic acid in bovine endothelial cells involves the activation of NFκB. Br. J. Pharmacol., 117, 239P.
2. AUGUET, M., LONCHAMPT, M.O., DELAFLOTTE, S., GOULINSCHULZ, J., CHABRIER, P.E. & BRAQUET, P. (1992). Induction of nitric oxide synthase by lipoteichoic acid from staphylococcus aureus in vascular smooth muscle cells. FEBS Lett., 297, 183-185.
3. BAUE, A.E. (1993). The multiple organ or system failure syndrome. In Pathophysiology of Shock, Sepsis and Organ Failure. ed. Schlag, G. & Redl, H., pp. 1004-1018. Berlin: Springer Verlag.
4. BECKMAN, J., BECKMAN, T., CHEN, J., MARSHALL, P. & FREEMAN, B. (1990). Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A., 87, 1620-1624.
5. BEUTLER, B., KROCHIN, N., MILSARK, I.W., LUEDKE, C. & CERAMI, A. (1986). Control of cachectin (tumour necrosis factor) synthesis: mechanisms of endotoxin resistance. Science, 232, 977-980.
6. BIEGANSKI, T., KUSCHE, J., LORENZ, W., HEXTERBERG, R., STAHLKNECHT, C.D. & FEUSSNER, K.D. (1983). Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine metabolism. Biochem. Biophys. Acta, 31, 196-203.
7. BONE, R.C. (1994). Gram-positive organisms and sepsis. Arch. Intern. Med., 154, 26-34.
8. BRADFORD, M.M (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem., 72, 248-254.
9. BROWNLEE, M., CERAMI, A. & VLASSARA, H. (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Eng. J. Med., 318, 1315-1321.
10. CORBETT, J.A., TILTON, R.G., CHANG, K., HASAN, K.S., IDO, Y., SON, J.R. & MCDANIEL, M.L. (1992). Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes, 41, 552-556.
11. CRONSTEIN, B.N., KIMMEL, S.C., LEVIN, R.I., MARTINUK, F. & WEISSMAN, W. (1992). A mechanism for the anti-inflammatory effects of cortico-steroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial leukocyte adhesion molecule-1 and intracellular adhesion molecule-1. Proc. Natl. Acad. Sci. U.S.A., 89, 9991-9995.
12. CUNHA, F.Q., MOSS, D.W., LEAL, L.M.C.C., MONCADA, S. & LIEW, F.Y. (1993). Induction of macrophage parasiticidal activity by staphylococcus aureus and exotoxins through the nitric oxide synthase pathway. Immunology, 78, 563-567.
13. CURRAN, R.D., FERRARI, F.K., KISPERT, P.H., STADLER, J., STUEHR, D.J., SIMMONS, R.L. & BILLIAR, T.R. (1991). Nitric oxide and nitrix oxide generating compounds inhibit hepatocyte protein synthesis. FASEB J., 5, 2085-2092.
14. DE KIMPE, S.J., HUNTER, M.L., BRYANT, C.E., THIEMERMANN, C. & VANE, J.R. (1995a). Delayed circulation failure due to the induction of nitric oxide synthase by lipoteichoic acid from staphylococcus aureus in anaesthetised rats. Br. J. Pharmacol., 114, 1317-1323.
15. DE KIMPE, S.J., KENGATHARAN, M., THIEMERMANN, C. & VANE, J.R. (1995b). The cell wall components peptidoglycan and lipoteichoic acid from staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. U.S.A., 92, 10359-10363.
16. DEITSCH, E.A (1992). Multiple organ failure. Ann. Surg., 216, 117-134.
17. EDELSTEIN, D. & BROWNLEE, M. (1992). Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes, 41, 26-29.
18. FANTUZZI, G. & GHEZZI, P. (1993). Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases. Med. Inflamm., 2, 263-270.
19. FLOWER, R.J. (1988). Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol., 94, 987-1015.
20. FRY, D.E., PEARLSTEIN, L., FULTON, R.L. & POLK, H.C. (1980). Multiple system organ failure: the role of incontrolled infection. Arch. Surg., 115, 136-140.
21. GREEN, L.C., RUIZ DE LUZURIAGA, K. & WAGNER, D.A. (1981). Nitrate biosynthesis in man. Proc. Natl. Acad. Sci. U.S.A., 78, 7764-7768.
22. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
23. KANNER, J., HAREL, S. & GRANIT, R. (1991). Nitric oxide as an antioxidant. Arch. Biochem. Biophys., 289, 130-136.
24. KANNER, J., HAREL, S. & GRANIT, R. (1992). Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and haemoglobin. Lipids, 27, 46-49.
25. KENGATHARAN, M., DE KIMPE, S.J. & THIEMERMANN, C. (1996a). Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br. J. Pharmacol., 117, 1163-1170.
26. KENGATHARAN, M., DE KIMPE, S.J. & THIEMERMANN, C. (1996b). Pre-treatment with dexamethasone or delayed treatment with aminoguanidine ameliorates the circulatory failure and organ injury in a rat model of Gram-positive shock. Br. J. Pharmacol., 118, 2P.
27. KENGATHARAN, M., DE KIMPE, S.J., THIEMERMANN, C. & VANE, J.R. (1996c). Effect of aminoguanidine on the circulatory failure and organ injury elicited by staphylococcal lipoteichoic acid and peptidoglycan in the anaesthetised rat. Br. J. Pharmacol., 117, 53P.
28. LEPOIVRE, M., FIESCHI, F., COVES, J., THELANDER, L. & FONTECAVE, M. (1991). Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun., 179, 442-448.
29. MASFERRER, J.L., SEIBERT, K., ZWEIFEL, B.S. & NEEDLEMAN, P. (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A., 89, 3917-3921.
30. MILES, A.M., BOHLE, D.S., GLASSBRENNER, P.A., HANSER, B., WINK, D.A. & GRISHAM, M.B. (1996). Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J. Biol. Chem., 271, 40-47.
31. MISKO, T.P., MOORE, W.M., KGOTEN, T.P., NICKOLS, G.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 233, 119-125.
32. MORRIS, S.M. JR. BILLIAR, T.R. (1994). New insights into the regulation of inducible nitric oxide syntheses. Am. J. Physiol., 266, E829-E839.
33. NATHAN, C. (1992). Nitric oxide as a secretary product of mammalian cells. FASEB J., 6, 3051-3064.
34. NIEMANN, A., BJORKLUND, A. & EIZIRIK, D.L. (1994). Studies on the molecular regulation of the inducible form of nitric-oxide synthase (iNOS) in insulin-producing cells. Molec. Cellular. Endocrinol., 106, 151-155.
35. OU, P. & WOLFF, S.P. (1993). Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol., 46, 1139-1144.
36. PARENTE, L. & FLOWER, R.J. (1985). The generation of lyso-PAF in experimental inflammation. In Inflammatory Mediators. ed. Higgs, G.A. & Williams, T.J. pp. 65-71. Basingstoke: Macmillan Press.
37. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 87, 10043-10047.
38. ROGERS, N.E. & IGNARRO, L.J. (1992). Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem. Biophys. Res. Commun., 189, 242-249.
39. RUETTEN, H., SOUTHAN, G.J., ABATE, A. & THIEMERMANN, C. (1996). Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br. J. Pharmacol., (in press).
40. SCHMIDT, H.H.H.W., WARNER, T.D., NAKANE, M., FORSTERMANN, U. & MURAD, F. (1992). Regulation and subcellular location of nitric oxide synthases in RAW264.7 macrophages. J. Exp. Pharmacol. Ther., 41, 615-624.
41. SEILER, N., BOLENIUS, F.N. & KNODGEN, B. (1985). The influence of catabolic reactions on polyamine excretion. Biochem. J., 225, 219-226.
42. STADLER, J., HARBRECHT, B.G., DI SILVIO, M., CURRAN, R.D., JORDAN, M.L., SIMMONS, R.L. & BILLIAR, T.R. (1993). Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukoc. Biol., 53, 165-172.
43. STAMLER, J.S. (1996). A radical vascular connection. Nature, 380, 108-111.
44. STEWART, K.D., BRACKETT, D.J., LERNER, M.R., ARCHER, L.T. & WILSON, M.F. (1994). Comparison of Staphylococcus aureus and Escherichia coli infusion in conscious rats. J. Surg. Res., 56, 60-66.
45. SZABO, C., MITCHELL, J.A., THIEMERMANN, C. & VANE, J.R. (1993a). Nitric oxide mediated hyporeactivity to noradrenaline precedes nitric oxide synthase induction in endotoxin shock. Br. J. Pharmacol., 108, 786-792.
46. SZABO, C., THIEMERMANN, C., WU, C.C., PERRETTI, M. & VANE, J.R. (1993b). Inhibition of nitrix oxide synthase induction by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc. Natl. Acad. Sci. U.S.A., 91, 271-275.
47. THEISSEN, J.L., LOICK, H.M., CURRY, B.B., TRABER, L.D., HERNDON, D.N. & TRABER, D.L. (1991). Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanaesthetised sheep. J. Appl. Physiol., 70, 2120-2125.
48. THIEMERMANN, C. (1995). Selective inhibition of the activity of inducible nitric oxide synthase in septic shock. Prog. Clin. Biol. Res., 392, 383-392.
49. THIEMERMANN, C., RUETTEN, H., WU, C.C. & VANE, J.R. (1995). The multiple organ dysfunction syndrome caused by endotoxin in the rat - attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br. J. Pharmacol., 116, 2845-2851.
50. THIEMERMANN, C., WU, C.C., SZABO, C., PERRETTI, M. & VANE, J.R. (1993). Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol., 110, 177-182.
51. VILLAMOR, E., PEREZ-VIZCAINO, RUIZ, T., LEZA, J.C., MORO, M. & TAMARGO, J. (1995). Group B Streptococcus and E.coli LPS-induced NO-dependent hyporesponsiveness to noradrenaline in isolated intrapulmonary arteries of neonatal piglets. Br. J. Pharmacol., 115, 261-266.
52. G-monomethyl-L-arginine. Biochem. J., 316, 209-215.
53. WINK, D.A. OSAWA, Y., DARBYSHIRE, J.F., JONES, C.R., ESHENAUR, S.C. & NIMS, R.W. (1993). Inhibition of cytochromes P450 by nitric oxide and a nitric oxide releasing agent. Arch. Biochem. Biophys., 300, 115-123.
54. WIZEMANN, T.M., GARDNER, C.R., LASKIN, J.D., QUINONES, S., DURHAM, S.K., GOLLER, N.L., OHNISHI, S.T. & LASKIN, D.L. (1994). Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J. Leukoc. Biol., 56, 759-768.
55. WU, C.C., CHEN, S.-J., SZABO, C., THIEMERMANN, C. & VANE, J.R. (1995). Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol., 114, 1666-1672.
56. ZHANG, J. & SNYDER, S.H. (1992). Nitric oxide stimulates auto - ADP-ribosylation of glyceraldehyde - 3 - phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A., 89, 9382-9385.